Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

Fox News senior national correspondent Rich Edson reports on the status of a vaccine that could potentially block fentanyl overdose on 'America's Newsroom.' ...

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss a potential fentanyl vaccine from ARMR ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

French biotech company Abivax's shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly could ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

The Atlas Venture partner, reflecting on two decades of investing, advises against rushing into IPOs and notes luck’s role in ...

The CEO foresees a "snowball effect" of life sciences companies coming to Dallas, but a couple things need to happen first.

The company recently shook up its leadership structure as it pursues a Phase 2 study.

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...